168
Participants
Start Date
March 30, 2017
Primary Completion Date
September 1, 2022
Study Completion Date
October 1, 2022
eCGM (enhanced CGM)
Glucose (CGM and Bluetooth BG meter), insulin (pump or Bluetooth insulin pen) and activity data will be automatically uploaded via the subjects' tablet computers, and analyzed by the CDS. The CDS will, if indicated generate adjustable insulin dosing recommendations that will compensate for different insulin requirements following high vs low activity days. The recommendations of the CDS will be used by the clinical team in their therapeutic decision-making about insulin dosing adjustments at the scheduled study follow up visits and the remote visits between these in-person visits. In addition, study staff will provide recommendations regarding hypoglycemic warning symptoms, causes, and appropriateness of treatment.
Joslin Diabetes Center, Boston
Beth Israel Deaconess Medical Center
OTHER
Boston Children's Hospital
OTHER
RTI International
OTHER
Joslin Diabetes Center
OTHER